Comparative Pharmacology
Head-to-head clinical analysis: GLYCOLAX versus MIRALAX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GLYCOLAX versus MIRALAX.
GLYCOLAX vs MIRALAX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic laxative. Polyethylene glycol (PEG) increases intraluminal water volume in the colon by osmosis, promoting stool passage and relieving constipation.
Polyethylene glycol 3350 (PEG 3350) is an osmotic laxative that works by retaining water in the stool through hydrogen bonding, increasing fecal water content and promoting bowel movements.
17 g (1 heaping tablespoon) dissolved in 4-8 ounces of liquid once daily, orally.
17 g (1 heaping tablespoon) dissolved in 4–8 oz of water, juice, soda, coffee, or tea, administered orally once daily. Maximum duration of use: 7 days.
None Documented
None Documented
Not applicable due to negligible systemic absorption; local colonic transit time approximately 2-4 hours.
Not applicable; polyethylene glycol 3350 is minimally absorbed and systemic half-life is not clinically relevant.
Minimally absorbed; excreted primarily unchanged in feces via osmotic action. Renal excretion negligible (<0.2% absorbed dose).
Primarily excreted unchanged in feces (>90% of oral dose); negligible renal elimination (<0.1% recovered in urine).
Category C
Category C
Osmotic Laxative
Osmotic Laxative